|
2008 |
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2013 |
Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. |
Victor Hruby, Ph.D., Todd Vanderah, PhD |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2011 |
Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD, FAAPS |
|
2009 |
Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. |
Patrick W Mantyh |
|
2012 |
Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid. |
Roberta Diaz Brinton, Ph.D |
|
2013 |
Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. |
Roberta Diaz Brinton, Ph.D |
|
2010 |
Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD |
|
2008 |
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2022 |
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies. |
Mohab M. Ibrahim, PhD, MD, Laurent F Martin |
|
2004 |
Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. |
|
|
2015 |
Perimenopause as a neurological transition state. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2006 |
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161. |
|
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2014 |
Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons. |
Tally Largent-Milnes, PhD |
|
2015 |
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. |
John M. Streicher, PhD |
|
2020 |
Potential therapeutic treatments of cancer-induced bone pain. |
Todd Vanderah, PhD |
|
2013 |
Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. |
Roberta Diaz Brinton, Ph.D |
|
2022 |
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache. |
Trent Anderson, Edita Navratilova, Frank Porreca, PhD |
|
2010 |
Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. |
John M. Streicher, PhD |
